Scholars Central

Conference abstract

Cord blood derived unrestricted somatic stem cells ameliorate experimentally induced chronic liver fibrosis

Authors: Hanan Gamal El Baz

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cord blood derived Unrestricted Somatic Stem Cells (CBUSSCs) with their multipotentiality hold great promise in liver regeneration. In this study the therapeutic potentiality of USSCs in two experimental models of chronic liver injury was evaluated. First Experimental model (50 mice): Thirty Schistosoma mansoni infected mice were IV injected with USSCs 1?106 cell/mouse. Ten were infected untreated (pathological control) and 10 healthy mice (negative control). 2nd experimental model (30 hamsters): Twenty were injected with repeated doses of CCl4 to induce liver fibrosis; 10 were treated with intrahepatic injection of 3x106 USSCs and the other 10 were untreated pathological control. Ten healthy hamsters served as negative control. Animals were sacrificed 3 months after treatment. The extent of liver fibrosis before and after USSCs injection was assessed histopathologically using H&E and sirius red staining and by measuring serum levels of ALT, AST, albumin and bilirubin. Liver sections were immunohistochemically stained for detection of human hepatocyte markers; Hep Par1, α-fetoprotein, CK-18, CK-7 and OV6. Phenotypic and molecular characterizations of CBUSSCs showed high expression levels of CD44, CD90, CD73 and CD105 and were negative for CD34, CD45 and HLA-DR and also showed high expression of transcripts for Oct4 and Sox2. In both models transplantation of CBUSSCs resulted in engraftment of the fibrosed livers with newly formed hepatocytes evidenced by positive immunostaining with human Hep Par1, α-fetoprotein, CK-18, CK-7 and OV6. Transplanted liver sections showed diminished hepatic fibrosis with significantly lower fibrotic index as well as significantly improved liver functions compared to the pathological control (p<0.001). Conclusions: Our results provide hope that CBUSSCs could be introduced as multipotent stem cells with great potentiality in regenerative medicine and strengthens the concept of cellular therapy for the treatment of liver fibrosis. This work is extracted from the project 1410 supported by the Science and Technology Development Funds (STDF), Cairo, Egypt.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Hanan Gamal El Baz”